Pure BiologicsSTU:PQB -1.94%19 Days Inventory is 0.00 as of Mar. 2026. GuruFocus rates STU:PQB with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 635 Biotechnology companies, Pure Biologics ranks worse than 157480.16% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Pure Biologics's Average Total Inventories for the
three
months ended in Mar. 2026 was €0.00 Mil. Pure Biologics's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €0.00 Mil.
Hence, Pure Biologics's Days Inventory for the
three
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Pure Biologics's Days Inventory or its related term are showing as below:
During the past 10 years, Pure Biologics's highest Days Inventory was 108.80. The lowest was 4.24. And the median was 49.06.
STU:PQB's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 183.23 * Ranked among companies with meaningful Days Inventory only.
Pure Biologics's Days Inventory
stayed the same
from Mar. 2025 (0.00) to Mar. 2026 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pure Biologics (STU:PQB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Pure Biologics's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pure Biologics's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Pure Biologics Days Inventory Related Terms
Pure Biologics Days Inventory Historical Data
* Premium members only.
The historical data trend for Pure Biologics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:PQB vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Pure Biologics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pure Biologics Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Pure Biologics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Pure Biologics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pure Biologics (STU:PQB) has a Days Inventory of 0.00 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pure Biologics and its competitors. Over the past decade, Pure Biologics' Days Inventory has ranged from 4.24 to 108.80. According to the industry distribution chart, Pure Biologics ranks #999999 out of 635 companies in the Biotechnology industry.
Is Pure Biologics' Days Inventory too high?
Pure Biologics' current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 4.24 to a high of 108.80. Based on the distribution chart, Pure Biologics ranks #999999 out of 635 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Pure Biologics has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Pure Biologics' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pure Biologics ranks #999999 out of 635 companies for Days Inventory. This places Pure Biologics in the lower half of its industry. The industry median Days Inventory is 183.23. Historically, Pure Biologics' own Days Inventory has ranged from 4.24 to 108.80 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pure Biologics and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pure Biologics's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pure Biologics stock overvalued right now?
Pure Biologics (STU:PQB) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Pure Biologics' overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Pure Biologics (STU:PQB), the current Days Inventory is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.
19GF Score
Get the complete analysis for STU:PQB
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:PQB has been successfully added to your 
